Efficacy of niraparib by timing of surgery and residual disease: A post-hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study Meeting Abstract


Authors: O'Cearbhaill, R.; Pérez-Fidalgo, J. A.; Monk, B.; Tusquets, I.; McCormick, C.; Fuentes, J.; Moore, R.; Vulsteke, C.; Shahin, M.; Forget, F.; Bradley, W.; Hietanen, S.; O'Malley, D.; Dørum, A.; Slomovitz, B.; Baumann, K.; Selle, F.; Calvert, P.; Artioli, G.; Levy, T.; Kumar, A.; Malinowska, I.; Li, Y.; Gupta, D.; González-Martín, A.
Abstract Title: Efficacy of niraparib by timing of surgery and residual disease: A post-hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
Meeting Title: 2021 Society of Gynecologic Oncology - 52nd Annual Meeting on Women's Cancer
Journal Title: Gynecologic Oncology
Volume: 162
Issue: Suppl. 1
Meeting Dates: 2021 Mar 19-25
Meeting Location: Virtual
ISSN: 0090-8258
Publisher: Elsevier Inc.  
Date Published: 2021-08-01
Start Page: S65
Language: English
ACCESSION: WOS:000687070800111
PROVIDER: wos
DOI: 10.1016/S0090-8258(21)00765-4
Notes: Meeting Abstract: 113 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors